1 Cardiovascular disease risk profiles. KM Anderson, PM Odell, PW Wilson, WB Kannel. abstract
2 Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score. A Mocroft, B Ledergerber, K Zimler, O Kirk, B Hirschel, JP Viard, P Reiss, P Francioli, A Lazzarin, L Machala, AN Phillips, JD Lundgren; the EuroSIDA study group and the Swiss HIV Cohort Study. abstract
3 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. AS Levey, JP Bosch, JB Lewis, T Greene, N Rogers, D Roth. abstract
4 Predicting the risk of cardiovascular disease in HIV-infected patients: the Data Collecton on Adverse Effects of Anti-HIV Drugs Study. N Friis-Møller, R Thiébaut, P Reiss, R Weber, AD Monforte, S De Wit, W El-Sadr, E Fontas, S Worm, O Kirk, A Phillips, C Sabin, JD Lundgren, M Law; for the DAD study group.
Eur J Cardiovasc Prev Rehabil. 2010 Jun 10. abstract
5 Implementing the number needed to harm in clinical practice: Risk of myocardial infarction in HIV-1 infected patients treated with abacavir. JD Kowalska, O Kirk, A Mocroft, L Høj, N Friis-Møller, P Reiss, I Weller, JD Lundgren.
HIV Med 2010;11(3):200-208. abstract